News Buzz: General Motors Company (NYSE:GM), Planar Systems Inc. (NASDAQ:PLNR), Golden Star Resources, (NYSEMKT:GSS), Enzo Biochem Inc. (NYSE:ENZ), INSYS Therapeutics (NASDAQ:INSY)

On Friday shares of General Motors Company (NYSE:GM) closed at $35.32. Company’s sales growth for last 5 years was 8.30% and EPS growth for next 5 years is recorded as 18.16%. General Motors Company (NYSE:GM) will invest $174 million in its Fairfax plant in Kansas City, Kansas, to pay for new equipment and technology to produce the 2016 Malibu, company officials announced Monday.

Planar Systems Inc. (NASDAQ:PLNR) in last trading activity moved down -23.26% to close at $4.75. Company weekly performance is -21.49% while its quarterly performance stands at -30.15%. Planar Systems Inc. (NASDAQ:PLNR) is -48.20% away from its 52 week high. Planar Systems Inc. (NASDAQ:PLNR) on Thursday reported fiscal second-quarter earnings of $1.6 million. On a per-share basis, the Beaverton, Oregon-based company said it had net income of 7 cents. Earnings, adjusted for one-time gains and costs, were 8 cents per share.

On last trading day Golden Star Resources, Ltd. (NYSEMKT:GSS) advanced 14.21% to close at $0.26. Its volatility for the week is 9.20% while volatility for the month is 6.26%. GSS’s sales growth for past 5 years was -3.90% and its EPS growth for past 5 years was -41.10%. Golden Star Resources, Ltd. (NYSEMKT:GSS) monthly performance is 17.27%. Golden Star Resources, Ltd. (NYSEMKT:GSS) announces that it has filed a technical report, prepared in accordance with National Instrument 43-101 regarding a Feasibility Study on the development of an underground mining operation at its currently operating Wassa open pit mine in Ghana.

Enzo Biochem Inc. (NYSE:ENZ) has 17.52% insider ownership while its institutional ownership stands at 54.70%. In last trading activity company’s stock closed at $2.56. Enzo Biochem (NYSE:ENZ) was downgraded by Zacks from a “hold” rating to a “sell” rating in a research report issued on Monday.

On last trading day INSYS Therapeutics, Inc. (NASDAQ:INSY) advanced 0.78% to close at $55.58. Its volatility for the week is 4.46% while volatility for the month is 5.62%. INSY’s EPS growth for past 5 years was 17.30%. INSYS Therapeutics, Inc. (NASDAQ:INSY) monthly performance is -4.02%. On May 7, Insys Therapeutics, Inc. (NASDAQ:INSY) announced its financial results for the three-month period ended March 31, 2015. Total net revenue increased to $70.8 million versus $41.6 million for the first quarter of 2014; and net income of $8.0 million, or $0.23 per basic and $0.21 per diluted share, compared to net income of $7.7 million, or $0.23 per basic and $0.21 per diluted share, for the first quarter of 2014.

Leave a Reply

Your email address will not be published. Required fields are marked *

*